Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

The SwissFEL soft X-ray free-electron laser beamline: Athos.

Abela R, Alarcon A, Alex J, Arrell C, Arsov V, Bettoni S, Bopp M, Bostedt C, Braun HH, Calvi M, Celcer T, Craievich P, Dax A, Dijkstal P, Dordevic S, Ferrari E, Flechsig U, Follath R, Frei F, Gaiffi N, Geng Z, Gough C, Hiller N, Hunziker S, Huppert M, Ischebeck R, Jöhri H, Juranic P, Kalt R, Kaiser M, Keil B, Kittel C, Künzi R, Lippuner T, Löhl F, Marcellini F, Marinkovic G, Ozkan Loch C, Orlandi GL, Patterson B, Pradervand C, Paraliev M, Pedrozzi M, Prat E, Ranitovic P, Reiche S, Rosenberg C, Sanfilippo S, Schietinger T, Schmidt T, Schnorr K, Svetina C, Trisorio A, Vicario C, Voulot D, Wagner U, Wörner HJ, Zandonella A, Patthey L, Ganter R.

J Synchrotron Radiat. 2019 Jul 1;26(Pt 4):1073-1084. doi: 10.1107/S1600577519003928. Epub 2019 Jun 21.

2.

Passive Linearization of the Magnetic Bunch Compression Using Self-Induced Fields.

Penco G, Allaria E, Cudin I, Di Mitri S, Gauthier D, Spampinati S, Trovó M, Giannessi L, Roussel E, Bettoni S, Craievich P, Ferrari E.

Phys Rev Lett. 2017 Nov 3;119(18):184802. doi: 10.1103/PhysRevLett.119.184802. Epub 2017 Nov 1.

PMID:
29219607
3.

Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.

Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G; Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy; Nastasi.

J Am Soc Nephrol. 2018 Jan;29(1):283-294. doi: 10.1681/ASN.2017030258. Epub 2017 Oct 13.

4.

Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis.

Bettoni S, Galbusera M, Gastoldi S, Donadelli R, Tentori C, Spartà G, Bresin E, Mele C, Alberti M, Tortajada A, Yebenes H, Remuzzi G, Noris M.

J Immunol. 2017 Aug 1;199(3):1021-1040. doi: 10.4049/jimmunol.1601121. Epub 2017 Jun 26.

5.

Insights into the effects of complement factor H on the assembly and decay of the alternative pathway C3 proconvertase and C3 convertase.

Bettoni S, Bresin E, Remuzzi G, Noris M, Donadelli R.

J Biol Chem. 2017 Apr 14;292(15):6094. doi: 10.1074/jbc.A115.693119. No abstract available.

6.

Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.

Bettoni S, Bresin E, Remuzzi G, Noris M, Donadelli R.

J Biol Chem. 2016 Apr 8;291(15):8214-30. doi: 10.1074/jbc.M115.693119. Epub 2016 Feb 22. Retraction in: J Biol Chem. 2017 Apr 14;292(15):6094.

7.

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.

Iatropoulos P, Noris M, Mele C, Piras R, Valoti E, Bresin E, Curreri M, Mondo E, Zito A, Gamba S, Bettoni S, Murer L, Fremeaux-Bacchi V, Vivarelli M, Emma F, Daina E, Remuzzi G.

Mol Immunol. 2016 Mar;71:131-142. doi: 10.1016/j.molimm.2016.01.010. Epub 2016 Feb 16.

PMID:
26895476
8.

Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome.

Mele C, Lemaire M, Iatropoulos P, Piras R, Bresin E, Bettoni S, Bick D, Helbling D, Veith R, Valoti E, Donadelli R, Murer L, Neunhäuserer M, Breno M, Frémeaux-Bacchi V, Lifton R, Remuzzi G, Noris M.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1011-9. doi: 10.2215/CJN.08520814. Epub 2015 Apr 8.

9.

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.

Noris M, Galbusera M, Gastoldi S, Macor P, Banterla F, Bresin E, Tripodo C, Bettoni S, Donadelli R, Valoti E, Tedesco F, Amore A, Coppo R, Ruggenenti P, Gotti E, Remuzzi G.

Blood. 2014 Sep 11;124(11):1715-26. doi: 10.1182/blood-2014-02-558296. Epub 2014 Jul 18.

10.

Insights into PARP Inhibitors' Selectivity Using Fluorescence Polarization and Surface Plasmon Resonance Binding Assays.

Papeo G, Avanzi N, Bettoni S, Leone A, Paolucci M, Perego R, Quartieri F, Riccardi-Sirtori F, Thieffine S, Montagnoli A, Lupi R.

J Biomol Screen. 2014 Sep;19(8):1212-9. doi: 10.1177/1087057114538319. Epub 2014 Jun 10.

PMID:
24916412
11.

Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?

Marinozzi MC, Vergoz L, Rybkine T, Ngo S, Bettoni S, Pashov A, Cayla M, Tabarin F, Jablonski M, Hue C, Smith RJ, Noris M, Halbwachs-Mecarelli L, Donadelli R, Fremeaux-Bacchi V, Roumenina LT.

J Am Soc Nephrol. 2014 Sep;25(9):2053-65. doi: 10.1681/ASN.2013070796. Epub 2014 Mar 20.

12.

MYO1E mutations and childhood familial focal segmental glomerulosclerosis.

Mele C, Iatropoulos P, Donadelli R, Calabria A, Maranta R, Cassis P, Buelli S, Tomasoni S, Piras R, Krendel M, Bettoni S, Morigi M, Delledonne M, Pecoraro C, Abbate I, Capobianchi MR, Hildebrandt F, Otto E, Schaefer F, Macciardi F, Ozaltin F, Emre S, Ibsirlioglu T, Benigni A, Remuzzi G, Noris M; PodoNet Consortium.

N Engl J Med. 2011 Jul 28;365(4):295-306. doi: 10.1056/NEJMoa1101273. Epub 2011 Jul 14.

13.

Test of "crab-waist" collisions at the DAPhiNE Phi factory.

Zobov M, Alesini D, Biagini ME, Biscari C, Bocci A, Boni R, Boscolo M, Bossi F, Buonomo B, Clozza A, Delle Monache GO, Demma T, Di Pasquale E, Di Pirro G, Drago A, Gallo A, Ghigo A, Guiducci S, Ligi C, Marcellini F, Mazzitelli G, Milardi C, Murtas F, Pellegrino L, Preger MA, Quintieri L, Raimondi P, Ricci R, Rotundo U, Sanelli C, Serio M, Sgamma F, Spataro B, Stecchi A, Stella A, Tomassini S, Vaccarezza C, Schioppa M, Esposito M, Branchini P, Iacoangeli F, Valente P, Levichev E, Piminov P, Shatilov D, Smaluk V, Arnaud N, Breton D, Burmistrov L, Stocchi A, Variola A, Viaud BF, Bettoni S, Ohmi K, Teytelman D.

Phys Rev Lett. 2010 Apr 30;104(17):174801. Epub 2010 Apr 28.

PMID:
20482112
14.

The Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD) : characterization of the cohort.

Fernandes N, Bastos MG, Cassi HV, Machado NL, Ribeiro JA, Martins G, Mourão O, Bastos K, Ferreira Filho SR, Lemos VM, Abdo M, Vannuchi MT, Mocelin A, Bettoni SL, Valenzuela RV, Lima MM, Pinto SW, Riella MC, Qureshi AR, Divino Filho JC, Pecoits-Filho R; Brazilian Peritoneal Dialysis Multicenter Study.

Kidney Int Suppl. 2008 Apr;(108):S145-51. doi: 10.1038/sj.ki.5002616.

15.

Building knowledge driven and dynamically networked communities within European healthcare systems.

Savoldelli A, Bettoni S, Gadda L, Perdoni V.

Stud Health Technol Inform. 2004;103:338-42.

PMID:
15747938
16.

[Resistance of intensive care unit nurses to caring for conscious patients].

Rocha VK, Guaragni AS, Bettoni S.

Rev Gaucha Enferm. 1996 Jul;17(2):132-9. Portuguese.

PMID:
9277282
17.

Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8).

Rambaldi A, Bettoni S, Tosi S, Giudici G, Schirò R, Borleri GM, Abbate M, Chiaffarino F, Colotta F, Barbui T, et al.

Blood. 1993 Mar 1;81(5):1376-83.

18.

Transcriptional and post-transcriptional regulation of IL-1 beta, IL-6 and TNF-alpha genes in chronic lymphocytic leukaemia.

Rambaldi A, Bettoni S, Rossi V, Tini ML, Giudici G, Rizzo V, Bassan R, Mantovani A, Barbui T, Biondi A.

Br J Haematol. 1993 Feb;83(2):204-11.

PMID:
8457468
19.

Interleukin-1 regulates cytokine gene expression in human mesangial cells through the interleukin-1 receptor type 1.

Zoja C, Bettoni S, Morigi M, Remuzzi G, Rambaldi A.

J Am Soc Nephrol. 1992 Jun;2(12):1709-15.

20.

Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia.

Specchia G, Liso V, Capalbo S, Fazioli F, Bettoni S, Bassan R, Viero P, Barbui T, Rambaldi A.

Br J Haematol. 1992 Mar;80(3):310-6.

PMID:
1533785
21.

Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells.

Rambaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw AR, Dinarello CA, Cozzolino F.

Blood. 1991 Dec 15;78(12):3248-53.

22.

Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells.

Zoja C, Wang JM, Bettoni S, Sironi M, Renzi D, Chiaffarino F, Abboud HE, Van Damme J, Mantovani A, Remuzzi G, et al.

Am J Pathol. 1991 Apr;138(4):991-1003.

23.

Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony-stimulating factor.

Rambaldi A, Terao M, Bettoni S, Tini ML, Bassan R, Barbui T, Garattini E.

Blood. 1990 Dec 15;76(12):2565-71.

24.

Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia.

Cozzolino F, Torcia M, Bettoni S, Aldinucci D, Burgio VL, Petti MC, Rubartelli A, Barbui T, Rambaldi A.

Int J Cancer. 1990 Nov 15;46(5):902-7.

PMID:
1699903
25.
26.

Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia.

Biondi A, Rossi V, Bassan R, Barbui T, Bettoni S, Sironi M, Mantovani A, Rambaldi A.

Blood. 1989 Apr;73(5):1279-84.

Supplemental Content

Loading ...
Support Center